Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Tanabe licenses T-0632 to Zeria

May 8, 1997

Neose Technologies initiates phase II trials with antiulcer drug

May 8, 1997

Preliminary clinical results for Lexirin

May 8, 1997

Maxim starts clinical trial of Maxamine in hepatitis C

May 8, 1997

Kaneka discloses anti-H. pylori rifamycins

May 6, 1997

Prokinetic agents from Kyorin

May 6, 1997

Positive results from preclinical studies with darifenacin

May 5, 1997

Positive preclinical results for T-330 in animal models of gastric ulcers

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Compounds combining PAF antagonist and 5-ASA claimed by Uriach for IBD

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...